Abstract
Obese patients have been identified to have a poor prognosis and a higher risk of death from coronavirus disease-2019 (COVID-19). We present reports of two obese patients infected with COVID-19 with acute respiratory distress syndrome (ARDS) who showed improvement with high flow nasal cannula (HFNC). HFNC is a noninvasive oxygen delivery device which is capable of delivering a high concentration of oxygen that can reduce the requirement for tracheal intubation. HFNC is convenient to use, can reduce dyspnea without effecting the length of stay in ICU in these cases; and has a high merit to be used in selected patients requiring oxygen before attempting intubation and mechanical ventilation.
 Key words: ARDS; COVID-19; High flow nasal cannula; HFNC; Obese
 Citation: Mariati NMAS, Sugiarto A, Endriani E, Lestari R, Anindita K. High flow nasal cannula to prevent intubation in obese patient with COVID-19 induced ARDS: a case report. Anaesth pain intensive care 2021;25(2):212-216. DOI: 10.35975/apic.v25i2.1473
 Received: 18 November 2020, Reviewed: 24 November 2020, Accepted: 7 December 2020
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
